These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7776857)

  • 21. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
    J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection.
    Lau JY; King R; Tibbs CJ; Catterall AP; Smith HM; Portmann BC; Alexander GJ; Williams R
    J Med Virol; 1993 Apr; 39(4):292-6. PubMed ID: 8492101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
    Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation.
    Borghesio E; Rosina F; Smedile A; Lagget M; Niro MG; Marinucci G; Rizzetto M
    Hepatology; 1998 Mar; 27(3):873-6. PubMed ID: 9500721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of interferons in treating children with chronic hepatitis C.
    Matsuoka S; Mori K; Nakano O; Yuasa Y; Taguchi Y; Hayabuchi Y; Kuroda Y
    Eur J Pediatr; 1997 Sep; 156(9):704-8. PubMed ID: 9296534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.
    Tassopoulos NC; Karvountzis G; Touloumi G; Delladetsima JK; Papatheodoridis GV; Katsoulidou A; Retalis G; Hatzakis A
    Am J Gastroenterol; 1996 Sep; 91(9):1734-8. PubMed ID: 8792690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis delta superinfection during alpha-interferon treatment for hepatitis B.
    Craxì A; Di Marco V; Bruno R; Fabiano C
    Ital J Gastroenterol; 1992 Jan; 24(1):19-20; discussion 20-1. PubMed ID: 1571575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of pegylated interferon-α treatment for 24 months in chronic delta hepatitis and predictors of response.
    Karaca C; Soyer OM; Baran B; Ormeci AC; Gokturk S; Aydin E; Evirgen S; Akyuz F; Demir K; Besisik F; Kaymakoglu S
    Antivir Ther; 2013; 18(4):561-6. PubMed ID: 22976528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection.
    Gürakan F; Koçak N; Ozen H; Yüce A
    Pediatr Infect Dis J; 2000 Jan; 19(1):52-6. PubMed ID: 10643851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon.
    Farci P; Karayiannis P; Brook MG; Smedile A; Lai ME; Balestrieri A; Saldanha JA; Monjardino J; Gerin J; Thomas HC
    Q J Med; 1989 Nov; 73(271):1045-54. PubMed ID: 2623137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.
    Heidrich B; Yurdaydın C; Kabaçam G; Ratsch BA; Zachou K; Bremer B; Dalekos GN; Erhardt A; Tabak F; Yalcin K; Gürel S; Zeuzem S; Cornberg M; Bock CT; Manns MP; Wedemeyer H;
    Hepatology; 2014 Jul; 60(1):87-97. PubMed ID: 24585488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.
    Shiffman ML; Hofmann CM; Luketic VA; Sanyal AJ; Contos MJ; Mills AS
    Hepatology; 1996 Jul; 24(1):21-6. PubMed ID: 8707264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: a randomized prospective study comparing two dose schedules in Chinese patients.
    Yao GB; Ji YY; Xu DZ; Gao J; Wu XH; Zhang QB; Hu DC
    Hepatogastroenterology; 1999; 46(26):1059-64. PubMed ID: 10370667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis.
    Battegay M; Simpson LH; Hoofnagle JH; Sallie R; Di Bisceglie AM
    J Med Virol; 1994 Dec; 44(4):389-92. PubMed ID: 7897369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose alpha interferon treatment in chronic hepatitis B virus infection.
    Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; von Wussow P; Meisel H; Klein H
    Gut; 1993; 34(2 Suppl):S97-8. PubMed ID: 8314499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: a randomized prospective study comparing two dose schedules in Chinese patients.
    Yao G; Ji Y; Yang M; Xu D; Gao J; Wu X; Zhang Q; Hu D
    Chin Med J (Engl); 1998 Oct; 111(10):922-6. PubMed ID: 11189241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.
    Niro GA; Ciancio A; Gaeta GB; Smedile A; Marrone A; Olivero A; Stanzione M; David E; Brancaccio G; Fontana R; Perri F; Andriulli A; Rizzetto M
    Hepatology; 2006 Sep; 44(3):713-20. PubMed ID: 16941685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
    Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.